The liver as a crucial organ in the first line of host defense: The roles of Kupffer cells, natural killer (NK) cells and NK1.1 Ag+ T cells in T helper 1 immune responses

Immunological Reviews

Volumn 174, Issue , 2000, Pages 35-46

  Seki, Shuiji ^a   Habu, Yoshiko ^a   Kawamura, Toshihiko ^b   Takeda, Kazuyoshi ^c   Dobashi, Hiroshi ^a   Ohkawa, Takashi ^a   Hiraide, Hoshio ^a  

^a NATIONAL DEFENSE MEDICAL COLLEGE   (Japan)

^b NIIGATA UNIVERSITY   (Japan)

^c JUNTENDO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE PHASE PROTEIN; BACTERIUM LIPOPOLYSACCHARIDE; COMPLEMENT; GAMMA INTERFERON; INTERLEUKIN 12; INTERLEUKIN 8; MONOKINE; SUPERANTIGEN; T LYMPHOCYTE RECEPTOR;

ANIMAL CELL; BACTERIAL INFECTION; CELL DAMAGE; CONTROLLED STUDY; ENDOTHELIUM INJURY; HELPER CELL; HEMATOPOIETIC STEM CELL; HOST RESISTANCE; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IN SITU HYBRIDIZATION; KUPFFER CELL; LEUKOCYTE ACTIVATION; LIVER; LIVER CELL DAMAGE; MALE; METASTASIS; MOUSE; MUCOCUTANEOUS LYMPH NODE SYNDROME; MULTIPLE ORGAN FAILURE; NATURAL KILLER CELL; NATURAL KILLER CELL MEDIATED CYTOTOXICITY; NONHUMAN; ONTOGENY; PORTAL VEIN BLOOD FLOW; PRIORITY JOURNAL; REVIEW; T LYMPHOCYTE ACTIVATION; THYMOCYTE;

ANIMALS; ANTIGENS, BACTERIAL; CELL LINEAGE; CHILD, PRESCHOOL; CONCANAVALIN A; GRAM-POSITIVE BACTERIA; HUMANS; INTESTINAL ABSORPTION; KILLER CELLS, NATURAL; KUPFFER CELLS; LIPOPOLYSACCHARIDES; LIVER; LIVER CIRCULATION; LYMPHOCYTE ACTIVATION; LYMPHOKINES; MACROPHAGE ACTIVATION; MICE; MICE, SCID; MUCOCUTANEOUS LYMPH NODE SYNDROME; MULTIPLE ORGAN FAILURE; NEOPLASM CIRCULATING CELLS; NEOPLASM METASTASIS; PERITONITIS; RECEPTORS, ANTIGEN, T-CELL; RECEPTORS, ANTIGEN, T-CELL, GAMMA-DELTA; SHOCK, SEPTIC; SHWARTZMAN PHENOMENON; SUPERANTIGENS; T-LYMPHOCYTE SUBSETS; T-LYMPHOCYTES, CYTOTOXIC; TH1 CELLS;

EID: 0034070797     PISSN: 01052896     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1600-0528.2002.017404.x     Document Type: Review

References (107)

1. 1. Okuyama R, et al. Estrogen administration activates extrathymic T cell differentiation in the liver. J Exp Med 1992;175:661-669.
2. 2. Abo T, et al. Extrathymic pathways of T-cell differentiation in the liver and other organs. Int Rev Immunol 1994;11:61-102.
3. 3. Makino Y, et al. Extrathymic development of a T cells bearing invariant Vα14 Jα281 TCR. Int Rev Immunol 1994;11:31-46.
4. 4. Sato K, et al. Evidence for extrathymic generation of intermediate T cell receptor cells in the liver revealed in thymectomized, irradiated mice subjected to bone marrow transplantation. J Exp Med 1995;182:759-767.
5. int liver mononuclear cells. Eur J Immunol 1995;25:3365-3369.
6. + stem cells and thymocyte precursors in the livers of adult mice. J Exp Med 1996;184:687-693.
7. 7. Taniguchi H, Toyoshima T, Fukao K, Nakauchi H. Presence of hematopoietic stem cells in the adult liver. Nat Med 1996;2:198-203.
8. 8. Collins C, et al. RAG1, RAG2 and pre-T cell receptor α chain expression by adult human hepatic T cells: evidence for extrathymic T cell maturation. Eur J Immunol 1996;26:3114-3118.
9. 9. Seki S, et al. An appropriate in vitro culture condition for the induction of human TCR γδ positive cells by heat killed bacteria. J Immunol Methods 1991;139:31-40.
10. 10. Harday AC, et al. Structure, organization, and somatic rearrangement of T cell γ genes. Cell 1985;40:259-269.
11. 11. Winoto A, Baltimore D. Separate lineages of T cells expressing the αβ and γδ receptors. Nature 1989;338:430-433.
12. 12. Seki S, et al. Identification of activated T cell receptor γδ lymphocytes in the liver of tumor bearing host. J Clin Invest 1990;86:409-415.
13. 13. Ohteki T, et al. Predominant appearance of γδT lymphocytes in the liver after birth. A murine study and its biological significance. Eur J Immunol 1991;21:1733-1740.
14. 14. Seki S, Abo T, Ohteki T, Sugiura K, Kumagai K. Unusual αβT cells expanded in autoimmune lpr mice are probably a counterpart of normal T cells in the liver. J Immunol 1991;147:417-424.
15. 15. Seki S, Kono DH, Balderas RS, Theofilopoulos AN. Vβ repertoire of murine hepatic T cells: implication for selection mechanism of double-negative αβT cells. J Immunol 1994;153:637-646.
16. 16. Fowlkes BJ, et al. A novel population of T cell-receptor-αβ-bearing thymocytes which predominantly express a single β gene family. Nature 1987;329;251-253.
17. - T cell receptor-αβ thymocytes: variable influence of self-antigens on T cell receptor Vβ usage. J Immunol 1991;146:1134-1441.
18. - thymocytes with specific lymphokine secretion. Eur J Immunol 1993;23:307-310.
19. + T cell subset (Thy0) that secretes diverse cytokines and overexpress the Vβ8 T cell receptor gene family. J Exp Med 1993;176:269-274.
20. 20. Ohteki T, et al. Age dependent appearance of extrathymic T cells in the liver and their appearance in the periphery of older mice. J Immunol 1992;149:1562-1570.
21. + T cells are present within a population of intermediate TCR cells. J Immunol 1995;155:2972-2983.
22. 22. Tsukahara A, et al. Mouse liver T cells: their change with aging and in comparison with peripheral T cells. Hepatology 1997;26:301-309.
23. - T cells in mice and humans. J Exp Med 1994;180:1097-1106.
24. + cells in the liver of mice. J Exp Med 1994;180:699-704.
25. 25. Yamagiwa S, et al. Development of intraepithelial T lymphocytes in the intestine of irradiated SCID mice by adult liver hematopoietic stem cells from normal mice. J Hepatol 1999;30:681-688.
26. 32 labeled Escherichia coli and staphylococci by the reticuloendothelial system. J Exp Med 1959;110:27-48.
27. 27. Gregory SH, Barczynski LK, Wing EJ. Effector function of hepatocytes and Kupffer cells in the resolution of systemic bacterial infection. J Leuk Biol 1992;51:421-424.
28. 28. Steel DM, Whitehead AS. The major acute phase reactants: C-reactive protein, serum amyloid P component and serum amyloid A protein. Immunol Today 1994;15:81-88.
29. 29. Billiau A. γ-interferon: the match that lights the fire? Immunol Today 1988;9:37-40.
30. 30. Raetz CRH. Biochemistry of endotoxins. Annu Rev Biochem 1990;59:129-170.
31. 31. Trinchieri G. Interleukin 12: a proinflammatory cytokine with immunomodulatory functions that bridge innate resistance and antigen-specific adaptive immunity. Annu Rev Immunol 1995;13:251-276.
32. 32. Bancroft GJ, Schreiber RD, Unanue ER. Natural immunity: a T cell-independent pathway of macrophage activation, defined in the scid mouse. Immunol Rev 1991;124:5-24.
33. + αβ T cells with potent cytotoxicity in the liver of mice via IL-12 production from Kupffer cells. J Immunol 1996;156:2436-2442.
34. + αβ T cells with intermediate TCR induced in the liver of mice by IL-12. J Immunol 1995;154:4333-4340.
35. + cells activated by IL-12 as a major effect or in inhibition of experimental tumor metastasis. J Immunol 1996;156:3366-3373.
36. 36. Baker CC, Chaudry IH, Gaines HO, Baue AE. Evaluation of factors affecting mortality rate after sepsis in a murine cecal ligation and puncture model. Surgery 1983;94:331-335.
37. 37. Eskandari MK, Bolgos G, Miller C, Nguyen DT, DeForge LE, Remick DG. Antitumor necrosis factor antibody therapy fails to prevent lethality after cecal ligation and puncture or endotoxemia. J Immunol 1992;148:2724-2730.
38. 38. Seki S, et al. The role of liver NK cells and peritoneal macrophages in IFN-γ and IL-10 production in experimental bacterial peritonitis of mice. Infect Immun 1998;66:5286-5294.
39. int liver lymphocytes are down-regulated by Listeria monocytogenes. Eur J Immunol 1995;25:3321-3325.
40. 40. Emoto Y, Emoto M, Kaufmann SHE. Transient control of interleukin-4-producing natural killer cells in the livers of Listeria monocytogenes-infected mice by interleukin-12. Infect Immun 1997;65:5003-5009.
41. + natural killer T cells by Mycobacterium bovis Bacillus Calmette Guérin. Eur J Immunol 1999;29:650-659.
42. 42. Gregory SH, Jiang X, Wing EJ. Lymphokine-activated killer cells lyse Listeria-infected hepatocytes and produce elevated quantities of interferon-γ. J Infect Dis 1996;174:1073-1079.
43. 43. Scherer MT, Ignatowicz L, Winslow GM, Kappler JW, Marrack P. Superantigens: bacterial and viral proteins that manipulate the immune system. Annu Rev Cell Biol 1993;9:101-128.
44. 44. Paris AL, Herwaldt LA, Blum D, Schmid GP, Shands KN, Broome CV. Pathogenic findings in twelve fatal cases of toxic shock syndrome. Ann Intern Med 1982;96:852-857.
45. 45. Larkin SM, Williams DN, Osterholm MT, Tofte LW, Posalaky Z. Toxic shock syndrome: clinical, laboratory, and pathologic findings in nine fatal cases. Ann Intern Med 1982;96:858-864.
46. 46. Kappler J, et al. Vβ-specific stimulation of human T cells by staphylococcal toxins. Science 1989;244:811-813.
47. +T cells by bacterial superantigen primed Kupffer cells. Hepatology 1999;30:430-436.
48. 48. Ozman L, et al. Interleukin 12, interferon γ, and tumor necrosis factor α are the key cytokines of the generalized Shwartzman reaction. J Exp Med 1994;180:907-916.
49. 49. Wysocka M, et al. Interleukin-12 is required for interferon-γ production and lethality in lipopolysaccharide-induced shock in mice. Eur J Immunol 1995;25:672-676.
50. + T cells and their IFN-γ production in the generalized Shwartzman reaction. J Immunol 1998;160:3522-3527.
51. 51. Heremans H, Dillen C, van Damme J, Billiau A. Essential role for natural killer cells in the lethal lipopolysaccharide-induced Shwartzman-like reaction in mice. Eur J Immunol 1994;24:1155-1160.
52. 52. Kobayashi M, et al. Identification and purification of natural killer cell stimulatory factor (NKSF), a cytokine with multiple biologic effects on human lymphocytes. J Exp Med 1989;170:827-846.
53. 53. Stern AS, et al. Purification to homogeneity and partial characterization of cytotoxic lymphocyte maturation factor from human B-lymphoblastoid cells. Proc Natl Acad Sci USA 1990;87:6808-6812.
54. 54. Wolf SF, et al. Cloning of cDNA for natural killer cell stimulatory factor, a heterodimeric cytokine with multiple biologic effects on T and natural killer cells. J Immunol 1991;146:3074-3081.
55. 55. Schoenhaut DS, et al. Cloning and expression of murine IL-12. J Immunol 1992;148:3433-3440.
56. 56. Brunda MJ, et al. Antitumor and antimetastatic activity of interleukin 12 against murine tumors. J Exp Med 1993;178:1223-1230.
57. 57. Nastala CL, et al. Recombinant IL-12 administration induces tumor regression in association with IFN-γ production. J Immunol 1994;153:1697-1706.
58. 58. Gately MK, et al. Administration of recombinant IL-12 to normal mice enhances the cytolytic lymphocyte activity and induces the production of interferon-γ in vivo. Int Immunol 1994;6:157-167.
59. + αβT cells with intermediate TCR induced in the liver of mice by IL-12. J Immunol 1995;154:4333-4340.
60. + αβ T cells in the lung of euthymic and athymic mice. Immunology 1996;88:82-89.
61. +T cells on experimental hematogenous tumor metastasis in the liver and lung. Immunology 1997;92:561-566.
62. +T cells in IL-12-mediated rejection of tumors. Science 1997;278:1623-1626.
63. + T cells in IL-12-induced immune responses in vivo. J Immunol 1998;160:16-19.
64. 64. Hong S, et al. Lipid antigen presentation in the immune system: lessons learned from CD1d knockout mice. Immunol Rev 1999;169:31-44.
65. - αβ T cells in the peritoneal cavity: specific T cell receptor-mediated cytotoxicity and selective IFN-γ production against B cell leukemia and myeloma cells. J Immunol 1996;157:3925-3935.
66. + T cells as well as NK cells against intraperitoneal tumors in mice. Cell Immunol 1999;193:219-225.
67. +T cells by glycosylceramides. Science 1997;278:1626-1629.
68. 68. Tiegs G, Hentschel J, Wendel A. A T cell-dependent experimental liver injury in mice inducible by concanavalin A. J Clin Invest 1992;90:196-203.
69. 69. Mizuhara H, et al. T cell activation-associated hepatic injury: mediation by tumor necrosis factors and protection by interleukin 6. J Exp Med 1994;179:1529-1537.
70. 70. Ganter F, Leist M, Lohse AW, Germann PG, Tiegs G. Concanavalin A-induced T-cell-mediated hepatic injury in mice: the role of tumor necrosis factor. Hepatology 1995;21:190-198.
71. 71. Mizuhara H, et al. Critical involvement of interferon gamma in the pathogenesis of T-cell activation-associated hepatitis and regulatory mechanisms of interleukin-6 for the manifestations of hepatitis. Hepatology 1996;23:1608-1615.
72. + T cells for concanavalin A induced hepatic injury in mice. J Immunol 1997;159:1537-1542.
73. 73. Nishikage T, et al. Inhibition of concanavalin A-induced hepatic injury of mice by bacterial lipopolysaccharide via the induction of IL-6 and the subsequent reduction of IL-4: the cytokine milieu of concanavalin A hepatitis. J Hepatol 1999;31:18-26.
74. 74. Ferluga J, Allison AC. Role of mononuclear infiltrating cells in pathogenesis of hepatitis. Lancet 1978;2:610-611.
75. 75. Katschinski T, Galanos C, Coumbos A, Freudenberg MA. γ interferon mediates Propionibacterium acnes-induced hypersensitivity to lipopolysaccharide in mice. Infect Immun 1992;60:1994-2001.
76. 76. Tsuji H, et al. Tumor necrosis factor receptor p55 is essential for intrahepatic granuloma formation and hepatocellular apoptosis in a murine model of bacterium-insuced fulminant hepatitis. Infect Immun 1997;63:1892-1898.
77. 77. Tsutsui H, et al. IL-18 accounts for both TNF-α-and Fas ligand-mediated hepatotoxic pathways in endotoxin-induced liver injury in mice. J Immunol 1997;159:3961-3967.
78. + CTLs in vivo. J Immunol 1995;155:2564-2570.
79. 79. See DM, Khemka P, Sahl L, Bui T, Tilles JG. The role of natural killer cells in viral infections. Scand J Immunol 1997;46:217-224.
80. + thymocytes selected by MHC class I molecules. Science 1994;263:1774-1778.
81. + CD8 thymocytes. J Exp Med 1994;180:395-399.
82. + T lymphocytes. Science 1995;268:863-865.
83. 83. Smily ST, Kaplan MH, Grusby MJ. Immunoglobulin E production in the absence of interleukin-4-secreting CD1-dependent cells. Science 1997;275:977-979.
84. + T cell development and early IL-4 production in CD1-deficient mice. Immunity 1997;6:459-467.
85. 85. Mendiratta SK, Martin WD, Hong S, Boesteanu A, Joyce S, Van Kaer L. CD1d1 mutant mice are deficient in natural T cells that promptly produce IL-4. Immunity 1997;6:469-477.
86. 86. Brutkiewicz RR, Bennink JR, Yewdell JW, Bendelac A. TAP-independent, β2-microglobulin-dependent surface expression of functional mouse CD1.1. J Exp Med 1995;182:1913-1919.
87. +) T cells that express αβ T cell receptors in transporters associated with antigen presentation-1 null and thymus leukemia antigen positive mice. J Exp Med 1996;184:1579-1584.
88. 88. Yamada H, Ninomiya T, Hashimoto A, Tamada K, Takimoto H, Nomoto K. Positive selection of extrathymically developed T cells by self-antigens. J Exp Med 1998;188:779-784
89. 89. Crosbie OM, Reynolds M, McEntee G, Traynor O, Hegarty JE, O'Farrelly C. In vitro evidence for the presence of hematopoietic stem cells in the adult human liver. Hepatology 1999;29.1193-1198.
90. 90. Satoh M, et al. Cytotoxic γδ or αβ T cells with a natural killer cell marker, CD56, induced from human peripheral blood lymphocytes by a combination of IL-12 and IL-2. J Immunol 1996;157:3886-3892.
91. 91. Miyaji C, et al. Numerical and functional characteristics of lymphocyte subsets in centenarians. J Clin Immunol 1997;17:420-429.
92. + T cells which increase at tumor sites in patients with colorectal cancer. Clin Exp Immunol 1995;102:159-166.
93. - T cells in mice and humans. J Exp Med 1994;180:1097-106.
94. 94. Norris S, et al. Natural T cells in the human liver: cytotoxic lymphocytes with dual T cell and natural killer cell phenotype and function are phenotypically heterogeneous and include Vα24-JαQ and γδ T cell receptor bearing cells. Hum Immunol 1999;60:20-31.
95. 95. Ryan JC, Turck J, Niemi EC, Yokoyama WM, Seaman WE. Molecular cloning of the NK1.1 antigen, a member of the NKR-P1 family of natural killer cell activation molecules. J Immunol 1992;149:1631-1635.
96. 96. Kawasaki T, et al. New infantile acute febrile mucocutaneous lymph node syndrome prevailing in Japan. Pediatrics 1974;54:271-276.
97. 97. Kato H, et al. Fate of coronary aneurysms in Kawasaki disease: serial coronary angiography and long-term follow-up study. Am J Cardiol 1982;49.1758-1766.
98. 98. Suzuki A, et al. Coronary arterial lesions of Kawasaki disease: cardiac catheterization findings of 1100 cases. Pediatr Cardiol 1986;7:3-9.
99. 99. Curtis N, et al. Evidence for a superantigen mediated process in Kawasaki disease. Arch Dis Child 1995;72:308-311.
100. 100. Leung DYM, et al. Toxic shock syndrome toxin-secreting Staphylococcus aureus in Kawasaki syndrome. Lancet 1993;342:1385-1388.
101. 101. Furusho K, et al. High-dose intravenous γ-globulin for Kawasaki disease. Lancet 1984;ii:1055-1057.
102. 102. Newburger JW, et al. The treatment of Kawasaki syndrome with intravenous immunoglobilin. N Engl J Med 1986;315:341-347.
103. 103. Takata Y, et al. Inhibition of IL-12 synthesis of peripheral blood mononuclear cells stimulated with a bacterial superantigen by pooled human immunoglobulin: implication for its effect on Kawasaki disease. Clin Exp Immunol 1998;114:311-319.
104. 104. Takeshita S, et al. Bacterial lipopolysaccharide-bound neutrophils in the pathogenesis of Kawasaki disease. J Infect Dis 1999;179:508-512.
105. 105. Aronson FR, Libby P, Brandon EP, Janicka MW, Mier JW. IL-2 rapidly induces natural killer cell adhesion to human endothelial cells. A potential mechanism for endothelial injury. J Immunol 1988;141:158-163.
106. 106. Hotta O, Taguma Y, Yusa N, Ooyama M. Analysis of mononuclear cells in urine using flow cytometry in glomerular diseases. Kidney Int 1994;46 (Suppl):117-121.
107. 107. Furukawa S, et al. Peripheral blood monocyte/macrophages and serum tumor necrosis factor in Kawasaki disease. Clin Immunol Immunopathol 1988;48:247-251.